Your browser doesn't support javascript.
loading
Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases.
Schneider, Marcel André; Kim, Jeesun; Berlth, Felix; Sugita, Yutaka; Grimminger, Peter P; Wijnhoven, Bas P L; Overtoom, Hidde; Gockel, Ines; Thieme, René; Griffiths, Ewen A; Butterworth, William; Nienhüser, Henrik; Müller, Beat; Crnovrsanin, Nerma; Gero, Daniel; Nickel, Felix; Gisbertz, Suzanne; van Berge Henegouwen, Mark I; Pucher, Philip H; Khan, Kashuf; Chaudry, Asif; Patel, Pranav H; Pera, Manuel; Dal Cero, Mariagiulia; Garcia, Carlos; Martinez Salinas, Guillermo; Kassab, Paulo; Prado Castro, Osvaldo Antônio; Norero, Enrique; Wisniowski, Paul; Putnam, Luke Randall; Lombardi, Pietro Maria; Ferrari, Giovanni; Gudaityte, Rita; Maleckas, Almantas; Prodehl, Leanne; Castaldi, Antonio; Prudhomme, Michel; Lee, Hyuk-Joon; Sano, Takeshi; Baiocchi, Gian Luca; De Manzoni, Giovanni; Giacopuzzi, Simone; Bencivenga, Maria; Rosati, Riccardo; Puccetti, Francesco; D'Ugo, Domenico; Nunobe, Souya; Yang, Han-Kwang; Gutschow, Christian Alexander.
Afiliação
  • Schneider MA; Department of Surgery and Transplantation, University Hospital Zürich, Zurich, Switzerland.
  • Kim J; Department of Surgery, Seoul National University Hospital, Seoul, South Korea.
  • Berlth F; Department of General-, Visceral- and Transplant Surgery, University Medical Center Mainz, Mainz, Germany.
  • Sugita Y; Department of Surgery, University Hospital Tuebingen, Tuebingen, Germany.
  • Grimminger PP; Department of Gastroenterological Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Wijnhoven BPL; Department of General-, Visceral- and Transplant Surgery, University Medical Center Mainz, Mainz, Germany.
  • Overtoom H; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Gockel I; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Thieme R; Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.
  • Griffiths EA; Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.
  • Butterworth W; Department of Upper GI Surgery, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Nienhüser H; Department of Upper GI Surgery, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Müller B; Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Crnovrsanin N; Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Gero D; Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Nickel F; Department of Surgery and Transplantation, University Hospital Zürich, Zurich, Switzerland.
  • Gisbertz S; Department of General, Visceral, and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • van Berge Henegouwen MI; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Pucher PH; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
  • Khan K; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Chaudry A; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
  • Patel PH; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
  • Pera M; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
  • Dal Cero M; Department of Surgery, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK.
  • Garcia C; Department of Surgery, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK.
  • Martinez Salinas G; Gastrointestinal Unit, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
  • Kassab P; Gastrointestinal Unit, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
  • Prado Castro OA; Section of Gastrointestinal Surgery, Hospital Universitario del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Norero E; Section of Gastrointestinal Surgery, Hospital Universitario del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Wisniowski P; Department of Surgery, Hospital San Borja Arriarán, Santiago, Región Metropolitana, Chile.
  • Putnam LR; Department of Surgery, Hospital San Borja Arriarán, Santiago, Región Metropolitana, Chile.
  • Lombardi PM; Department of Surgery, Gastroesophageal and Bariatric Surgical Division, Santa Casa of São Paulo Medical School and Hospital, São Paulo, Brazil.
  • Ferrari G; Esophagogastric Surgery Unit, Digestive Surgery Department, Hospital Dr Sotero del Rio, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Gudaityte R; Esophagogastric Surgery Unit, Digestive Surgery Department, Hospital Dr Sotero del Rio, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Maleckas A; Division of Upper GI and General Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Prodehl L; Division of Upper GI and General Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Castaldi A; Division of Minimally Invasive Surgical Oncology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Prudhomme M; Division of Minimally Invasive Surgical Oncology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Lee HJ; Department of Surgery, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Sano T; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
  • Baiocchi GL; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
  • De Manzoni G; Department of Surgery, Seoul National University Hospital, Seoul, South Korea.
  • Giacopuzzi S; Department of Gastroenterological Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Bencivenga M; Department of Digestive Surgery and Digestive Oncology, Carémeau University Hospital, Nîmes, France.
  • Rosati R; Department of Surgery, University Hospital of Brescia, Brescia, Italy.
  • Puccetti F; Department of Surgery, University Hospital of Brescia, Brescia, Italy.
  • D'Ugo D; Department of Surgery, University Hospital of Brescia, Brescia, Italy.
  • Nunobe S; Department of Surgery, University Hospital of Verona, Verona, Italy.
  • Yang HK; Department of Surgery, University Hospital of Verona, Verona, Italy.
  • Gutschow CA; Department of Surgery, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Ann Surg ; 280(5): 788-798, 2024 Nov 01.
Article em En | MEDLINE | ID: mdl-39101212
ABSTRACT
OBJECTIVE/

BACKGROUND:

Various anastomotic and reconstruction techniques are used for minimally invasive total (miTG) and distal gastrectomy (miDG). Their effects on postoperative morbidity have not been extensively studied.

METHODS:

MiTG and miDG patients were selected from 9356 oncological gastrectomies performed in 2017-2021 in 43 centers. Endpoints included anastomotic leakage (AL) rate and postoperative morbidity tested by multivariable analysis.

RESULTS:

Three major anastomotic techniques [circular stapled (CS); linear stapled (LS); and hand sewn (HS)], and 3 major bowel reconstruction types [Roux (RX); Billroth I (BI); Billroth II (BII)] were identified in miTG (n=878) and miDG (n=3334). Postoperative complications, including AL (5.2% vs 1.1%), overall (28.7% vs 16.3%), and major morbidity (15.7% vs 8.2%), as well as 90-day mortality (1.6% vs 0.5%) were higher after miTG compared with miDG. After miTG, the AL rate was higher after CS (4.3%) and HS (7.9%) compared with LS (3.4%). Similarly, major complications (LS 9.7%, CS 16.2%, and HS 12.7%) were lowest after LS. Multivariate analysis confirmed anastomotic technique as a predictive factor for AL, overall, and major complications. In miDG, AL rate (BI 1.4%, BII 0.8%, and RX 1.2%), overall (BI 14.5%, BII 15.0%, and RX 18.7%), and major morbidity (BI 7.9%, BII 9.1%, and RX 7.2%), and mortality (BI 0%, BII 0.1%, and RY 1.1%%) were not affected by bowel reconstruction.

CONCLUSIONS:

In oncologically suitable situations, miDG should be preferred to miTG, as postoperative morbidity is significantly lower. LS should be a preferred anastomotic technique for miTG in Western Centers. Conversely, bowel reconstruction in DG may be chosen according to the surgeon's preference.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Neoplasias Gástricas / Fístula Anastomótica / Gastrectomia Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Surg Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Neoplasias Gástricas / Fístula Anastomótica / Gastrectomia Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Surg Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça